The ability of EK cells to form chimeras after selection of clones in G418 and some observations on the integration of retroviral vector proviral DNA into EK cells.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 3868502)

Published in Cold Spring Harb Symp Quant Biol on January 01, 1985

Authors

M J Evans, A Bradley, M R Kuehn, E J Robertson

Articles citing this

Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci U S A (1986) 3.11

Discovering pluripotency: 30 years of mouse embryonic stem cells. Nat Rev Mol Cell Biol (2011) 1.31

Articles by these authors

Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 30.49

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (1992) 25.54

Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91

Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell (1991) 14.89

p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature (1999) 13.21

Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev (2000) 11.49

The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell (1990) 10.99

Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell (1993) 10.36

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature (1995) 8.68

Role of insulin-like growth factors in embryonic and postnatal growth. Cell (1993) 8.22

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (1997) 8.04

Parental imprinting of the mouse insulin-like growth factor II gene. Cell (1991) 7.11

Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75

Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature (1984) 6.54

Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet (1996) 6.06

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (1995) 6.01

A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development (1999) 5.85

Impaired energy homeostasis in C/EBP alpha knockout mice. Science (1995) 5.68

Chromosome engineering in mice. Nature (1995) 5.48

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (1990) 5.47

Hemoglobin messenger ribonucleic acid. Synthesis of 9S and ribosomal ribonucleic acid during erythroid cell development. Biochemistry (1969) 5.37

Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A (1975) 4.95

Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91

The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature (1999) 4.74

Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (1986) 4.73

Requirement for Wnt3 in vertebrate axis formation. Nat Genet (1999) 4.68

Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell (2001) 4.61

The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell (1994) 4.58

Involvement of Brca2 in DNA repair. Mol Cell (1998) 4.41

Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature (2001) 4.41

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev (1995) 4.18

In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene (1993) 4.03

Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 3.91

An assessment of the developmental potential of embryonic stem cells in the midgestation mouse embryo. Development (1989) 3.90

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet (1993) 3.85

BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev (1995) 3.84

Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature (1991) 3.83

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev (1993) 3.60

Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57

Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (1992) 3.54

Eomesodermin is required for mouse trophoblast development and mesoderm formation. Nature (2000) 3.53

The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol (1989) 3.45

Relationship between asymmetric nodal expression and the direction of embryonic turning. Nature (1996) 3.42

Gene targeting in embryonic stem cells. Methods Enzymol (1993) 3.41

Axis development and early asymmetry in mammals. Cell (1999) 3.34

Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet (1995) 3.29

Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet (2000) 3.28

Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol Cell Biol (1991) 3.25

nodal expression in the primitive endoderm is required for specification of the anterior axis during mouse gastrulation. Development (1997) 3.15

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J (1998) 3.12

A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. Development (1994) 3.12

Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). J Biol Chem (1994) 3.09

Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol (1975) 3.07

Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A (1999) 3.06

Genomic DNA microextraction: a method to screen numerous samples. Anal Biochem (1992) 3.05

Multiple defects and perinatal death in mice deficient in follistatin. Nature (1995) 2.96

Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science (1989) 2.90

Renewal of alveolar epithelium in the rat following exposure to NO2. Am J Pathol (1973) 2.80

The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol (1991) 2.75

Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev (1992) 2.72

Mouse ENU mutagenesis. Hum Mol Genet (1999) 2.72

Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc Natl Acad Sci U S A (1998) 2.71

Height and surfacing as risk factors for injury in falls from playground equipment: a case-control study. Inj Prev (1996) 2.71

Functional analysis of activins during mammalian development. Nature (1995) 2.71

Nodal signalling in the epiblast patterns the early mouse embryo. Nature (2001) 2.65

The tumor suppressor p53. Biochim Biophys Acta (1993) 2.65

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62

Different phenotypes for mice deficient in either activins or activin receptor type II. Nature (1995) 2.62

Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell (1998) 2.60

Congenital heart disease in mice deficient for the DiGeorge syndrome region. Nature (1999) 2.60

Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J (1993) 2.57

Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev Dyn (1997) 2.55

Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature (1994) 2.54

Fate of teratocarcinoma cells injected into early mouse embryos. Nature (1975) 2.48

Hoxb-4 (Hox-2.6) mutant mice show homeotic transformation of a cervical vertebra and defects in the closure of the sternal rudiments. Cell (1993) 2.45

Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation. Nature (1993) 2.45

Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol (1996) 2.44

Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest (1978) 2.42

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev (1995) 2.41

Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature (1981) 2.35

Conserved left-right asymmetry of nodal expression and alterations in murine situs inversus. Nature (1996) 2.35

A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature (1987) 2.33

Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32

Gene targeting yields a CD18-mutant mouse for study of inflammation. J Immunol (1993) 2.32

Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature (1998) 2.29

Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med (1993) 2.27

The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum. Cell (1992) 2.27

Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A (1995) 2.27

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26

Local bone mineral response to brief exercise that stresses the skeleton. BMJ (1989) 2.25

Clinical and pharmacological properties of ivermectin in rabbits and guinea pigs. Vet Rec (1992) 2.21

Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene (1994) 2.20

Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell (1991) 2.19

Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog (1995) 2.18

The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17